|
DE296075C
(https=)
|
|
|
|
|
|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
JPS61100519A
(ja)
|
1984-10-23 |
1986-05-19 |
Shin Etsu Chem Co Ltd |
医薬用硬質カプセル
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DD296075A5
(de)
|
1989-08-07 |
1991-11-21 |
Martin-Luther-Universitaet Halle-Wittenberg,De |
Verfahren zur herstellung neuer inhibitoren der dipeptidyl peptidase iv
|
|
EP0528858B1
(en)
|
1990-04-14 |
1997-01-22 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type iv
|
|
US5462928A
(en)
|
1990-04-14 |
1995-10-31 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
ES2153831T3
(es)
|
1991-10-22 |
2001-03-16 |
New England Medical Center Inc |
Inhibidores de dipeptidil-aminopeptidasa de tipo iv.
|
|
MX9206628A
(es)
|
1991-11-22 |
1993-05-01 |
Boehringer Ingelheim Pharma |
Ester de prolinaboronato y metodo para su preparacion.
|
|
US5431917A
(en)
|
1992-10-08 |
1995-07-11 |
Japan Elanco Company, Ltd. |
Hard capsule for pharmaceutical drugs and method for producing the same
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5543396A
(en)
|
1994-04-28 |
1996-08-06 |
Georgia Tech Research Corp. |
Proline phosphonate derivatives
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
|
WO1998018763A1
(en)
|
1996-10-25 |
1998-05-07 |
Tanabe Seiyaku Co., Ltd. |
Tetrahydroisoquinoline derivatives
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
US6011155A
(en)
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US5736151A
(en)
|
1996-12-09 |
1998-04-07 |
Pharmacia & Upjohn Company |
Antibiotic oil suspensions
|
|
EP0996459B1
(en)
|
1997-01-07 |
2005-09-21 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the reduction of food intake
|
|
JP3957765B2
(ja)
|
1997-04-07 |
2007-08-15 |
ジェネンテク・インコーポレイテッド |
抗ｖｅｇｆ抗体
|
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
|
US6040145A
(en)
|
1997-05-07 |
2000-03-21 |
Tufts University |
Potentiation of the immune response
|
|
CA2304206A1
(en)
|
1997-09-29 |
1999-04-08 |
Point Therapeutics, Inc. |
Stimulation of hematopoietic cells in vitro
|
|
JP4095772B2
(ja)
|
1997-11-18 |
2008-06-04 |
財団法人微生物化学研究会 |
新規生理活性物質スルフォスチン、その製造法及びその用途
|
|
US6583157B2
(en)
*
|
1998-01-29 |
2003-06-24 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
CA2318731C
(en)
|
1998-01-29 |
2012-05-29 |
Tularik Inc. |
Ppar-gamma modulators
|
|
AU766219B2
(en)
|
1998-02-02 |
2003-10-09 |
1149336 Ontario Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
|
US20020061839A1
(en)
|
1998-03-09 |
2002-05-23 |
Scharpe Simon Lodewijk |
Serine peptidase modulators
|
|
CA2331122A1
(en)
|
1998-05-04 |
1999-11-11 |
Point Therapeutics, Inc. |
Hematopoietic stimulation
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
AU765370B2
(en)
|
1998-06-05 |
2003-09-18 |
Point Therapeutics, Inc. |
Cyclic boroproline compounds
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19834591A1
(de)
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
|
EP1104293A1
(en)
|
1998-08-21 |
2001-06-06 |
Point Therapeutics, Inc. |
Regulation of substrate activity
|
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
JP3449253B2
(ja)
|
1998-10-29 |
2003-09-22 |
シオノギクオリカプス株式会社 |
硬質カプセルの製造方法
|
|
JP2002538081A
(ja)
|
1998-12-07 |
2002-11-12 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
Ｇｌｐ−１の類似体
|
|
EP1137628A1
(en)
|
1998-12-09 |
2001-10-04 |
La Jolla Pharmaceutical Company |
Molecular scaffolds acting as templates comprising carbamate linkages
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
JP2000191616A
(ja)
|
1998-12-24 |
2000-07-11 |
Senju Pharmaceut Co Ltd |
新規ジペプチジルアルデヒド誘導体およびそれを含有する医薬
|
|
NZ512663A
(en)
|
1999-01-14 |
2004-05-28 |
Amylin Pharmaceuticals Inc |
Novel exendin agonist formulations and methods of administration thereof
|
|
JP3018186B1
(ja)
|
1999-03-09 |
2000-03-13 |
大阪大学長 |
抗炎症剤、単球系細胞の増殖抑制剤
|
|
GB9906714D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for improving fertility
|
|
GB9906715D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
|
US20050272652A1
(en)
|
1999-03-29 |
2005-12-08 |
Gault Victor A |
Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
|
|
JP3716901B2
(ja)
|
1999-04-14 |
2005-11-16 |
シオノギクオリカプス株式会社 |
セルロースエーテルフィルム
|
|
JP4121215B2
(ja)
|
1999-05-17 |
2008-07-23 |
財団法人微生物化学研究会 |
スルフォスチン類縁体、並びにスルフォスチン及びその類縁体の製造方法
|
|
EP1187619A1
(en)
|
1999-05-25 |
2002-03-20 |
Point Therapeutics, Inc. |
Anti-tumor agents comprising boroproline compounds
|
|
US6172081B1
(en)
|
1999-06-24 |
2001-01-09 |
Novartis Ag |
Tetrahydroisoquinoline 3-carboxamide derivatives
|
|
US6107317A
(en)
|
1999-06-24 |
2000-08-22 |
Novartis Ag |
N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6110949A
(en)
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
IL147308A0
(en)
|
1999-06-30 |
2002-08-14 |
Tularik Inc |
Compounds for the modulation of pparγ activity and pharmaceutical compositions containing the same
|
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
EP1228061A4
(en)
|
1999-11-12 |
2004-12-15 |
Guilford Pharm Inc |
DIPEPTIDYL PEPTIDASE IV INHIBITORS; METHODS OF MANUFACTURE AND USE OF SAID INHIBITORS
|
|
US20040152745A1
(en)
|
1999-11-12 |
2004-08-05 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
PT1741446E
(pt)
|
2000-01-21 |
2008-05-09 |
Novartis Pharma Ag |
Combinações incluindo inibidores da dipeptidilpeptidase-iv e agentes anti-diabéticos
|
|
AU2001228309A1
(en)
|
2000-01-24 |
2001-08-07 |
Novo-Nordisk A/S |
N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
|
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
|
HU229042B1
(en)
|
2000-03-31 |
2013-07-29 |
Prosidion Ltd |
Method for the improvement of islet signaling in diabetes mellitus and for its prevention
|
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
WO2001083427A1
(en)
|
2000-04-28 |
2001-11-08 |
Sankyo Company, Limited |
PPARη MODULATORS
|
|
WO2001082916A2
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Combination therapeutic compositions and methods of use
|
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
TW583185B
(en)
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
KR100771286B1
(ko)
|
2000-06-28 |
2007-10-29 |
암젠 인크 |
퀴놀리닐 및 벤조티아졸릴 ｐｐａｒ-감마 조절물질
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
WO2002002560A2
(en)
|
2000-07-04 |
2002-01-10 |
Novo Nordisk A/S |
Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)
|
|
US7074794B2
(en)
|
2000-08-10 |
2006-07-11 |
Mitsubishi Pharma Corporation |
Proline derivatives and the use thereof as drugs
|
|
JP4329290B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
脂肪族含窒素五員環化合物
|
|
JP2004035574A
(ja)
|
2000-10-06 |
2004-02-05 |
Tanabe Seiyaku Co Ltd |
脂肪族含窒素五員環化合物
|
|
US7138397B2
(en)
|
2000-10-06 |
2006-11-21 |
Tanabe Seiyaku Co., Ltd. |
Nitrogenous 5-membered ring compounds
|
|
JP4329291B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
含窒素五員環化合物
|
|
AUPR107800A0
(en)
|
2000-10-27 |
2000-11-23 |
University Of Sydney, The |
Peptide and nucleic acid molecule ii
|
|
TWI243162B
(en)
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
|
WO2002051836A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
DE10100053A1
(de)
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
|
JP2004520330A
(ja)
|
2001-01-02 |
2004-07-08 |
インスティテュート ヒューア メディツィンテクノロギー マグデブルク ゲーエムベーハー イーエムテーエム |
動脈硬化症の治療と予防的治療、ゲル−クームズ分類ｉ型のアレルギー反応の治療と予防、ならびに、毛包性および表皮性の過角化症とケラチノサイトの促進された増殖を伴う皮膚病の治療と予防のための、酵素阻害因子およびその薬剤化合物の併用
|
|
WO2002055088A1
(en)
|
2001-01-16 |
2002-07-18 |
Nippon Kayaku Kabushiki Kaisha |
Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents
|
|
JP4213390B2
(ja)
|
2001-02-02 |
2009-01-21 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
CN1500080A
(zh)
|
2001-02-02 |
2004-05-26 |
����ҩƷ��ҵ��ʽ���� |
稠合杂环化合物
|
|
KR100926247B1
(ko)
|
2001-02-24 |
2009-11-12 |
베링거 잉겔하임 파르마 게엠베하 운트 코 카게 |
크산틴 유도체를 포함하는 약제학적 조성물 및 이의제조방법
|
|
JP2002265439A
(ja)
|
2001-03-08 |
2002-09-18 |
Mitsubishi Pharma Corp |
シアノピロリジン誘導体およびその医薬用途
|
|
ATE395912T1
(de)
|
2001-03-27 |
2008-06-15 |
Merck & Co Inc |
Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
|
|
FR2822826B1
(fr)
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
|
GB0109146D0
(en)
|
2001-04-11 |
2001-05-30 |
Ferring Bv |
Treatment of type 2 diabetes
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US20030060494A1
(en)
|
2001-05-18 |
2003-03-27 |
Nobuyuki Yasuda |
Pharmaceutical use of N-carbamoylazole derivatives
|
|
EP1406872B1
(en)
|
2001-06-20 |
2007-12-19 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
ES2257555T3
(es)
|
2001-06-20 |
2006-08-01 |
MERCK & CO., INC. |
Inhibidores de dipeptidilpeptidasa para el tratamiento de la diabetes.
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
DE60221983T2
(de)
|
2001-06-27 |
2008-05-15 |
Smithkline Beecham Corp. |
Fluorpyrrolidine als dipeptidyl-peptidase inhibitoren
|
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
|
DE10154689A1
(de)
|
2001-11-09 |
2003-05-22 |
Probiodrug Ag |
Substituierte Aminoketonverbindungen
|
|
RU2299066C2
(ru)
|
2001-06-27 |
2007-05-20 |
Пробиодруг Аг |
Новые ингибиторы дипептидилпептидазы iv и их применение в качестве противораковых агентов
|
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
|
ES2296979T3
(es)
|
2001-06-27 |
2008-05-01 |
Smithkline Beecham Corporation |
Fluoropirrolidinas como inhibidores de dipeptidil peptidasa.
|
|
JP4300108B2
(ja)
|
2001-06-27 |
2009-07-22 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのピロリジン類
|
|
CA2418543A1
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
|
|
WO2003004496A1
(en)
|
2001-07-03 |
2003-01-16 |
Novo Nordisk A/S |
Dpp-iv-inhibiting purine derivatives for the treatment of diabetes
|
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
SG120880A1
(en)
|
2001-08-31 |
2006-04-26 |
Semiconductor Energy Lab |
Laser irradiation method, laser irradiation apparatus, and method of manufacturing a semiconductor device
|
|
DE10143840A1
(de)
|
2001-09-06 |
2003-03-27 |
Probiodrug Ag |
Neue Inhibitoren der Dipeptidylpeptidase I
|
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
|
WO2003024942A1
(en)
|
2001-09-14 |
2003-03-27 |
Mitsubishi Pharma Corporation |
Thiazolidine derivative and medicinal use thereof
|
|
EP1463727A2
(en)
|
2001-09-19 |
2004-10-06 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
|
GB0125446D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
|
GB0125445D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
CA2464995A1
(en)
|
2001-10-31 |
2003-05-08 |
Novartis Ag |
Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
|
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
|
US7236683B2
(en)
|
2001-11-15 |
2007-06-26 |
Macrovision Corporation |
Method and apparatus for providing or enhancing copy protection by adding selected negative-going and positive-going pulses in a video signal HBI
|
|
EP1469873A4
(en)
|
2001-11-26 |
2007-10-03 |
Tufts College |
PEPTIDOMIMETIC INHIBITORS FROM BEHIND PROLIN SPLENDING ENZYMES
|
|
WO2003045228A2
(en)
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Methods for treating autoimmune disorders, and reagents related thereto
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
US6725848B2
(en)
|
2002-01-18 |
2004-04-27 |
Detroit Diesel Corporation |
Method of controlling exhaust gas recirculation system based upon humidity
|
|
CA2475653A1
(en)
|
2002-02-08 |
2003-09-04 |
Idun Pharmaceuticals, Inc. |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
ES2252656T3
(es)
|
2002-02-13 |
2006-05-16 |
F. Hoffmann-La Roche Ag |
Nuevos derivados de piridina y quinolina.
|
|
KR100608414B1
(ko)
|
2002-02-13 |
2006-08-02 |
에프. 호프만-라 로슈 아게 |
신규한 피리딘- 및 피리미딘-유도체
|
|
US6906074B2
(en)
|
2002-02-22 |
2005-06-14 |
Nippon Zoki Pharmaceutical Co., Ltd. |
2-phenylpiperazine derivatives
|
|
DE60304911D1
(de)
|
2002-02-25 |
2006-06-08 |
Eisai Co Ltd |
Xanthin-Derivate als DPP-IV-Inhibitoren
|
|
JP2004043429A
(ja)
|
2002-02-25 |
2004-02-12 |
Eisai Co Ltd |
新規キサンチン誘導体およびｄｐｐｉｖ阻害剤
|
|
JP2005527504A
(ja)
|
2002-02-28 |
2005-09-15 |
プロシディオン・リミテッド |
グルタミニルを基礎するｄｐｉｖ阻害剤
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
WO2003080633A1
(fr)
|
2002-03-25 |
2003-10-02 |
Nippon Kayaku Kabushiki Kaisha |
Nouveau derive d'$g(a)-amino-n-(diaminophosphinyl)lactame
|
|
ATE373660T1
(de)
|
2002-03-25 |
2007-10-15 |
Merck & Co Inc |
Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
|
|
JP4329381B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
JP4329382B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
US20040106802A1
(en)
|
2002-04-08 |
2004-06-03 |
Torrent Pharmaceuticals Ltd. |
Novel compounds and therapeutic uses thereof
|
|
BR0308816A
(pt)
|
2002-04-08 |
2005-03-22 |
Torrent Pharmaceuticals Ltd |
Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas
|
|
JP2003300977A
(ja)
|
2002-04-10 |
2003-10-21 |
Sumitomo Pharmaceut Co Ltd |
キサンチン誘導体
|
|
JP2004026820A
(ja)
|
2002-05-09 |
2004-01-29 |
Taisho Pharmaceut Co Ltd |
ジペプチジルペプチダーゼｉｖ阻害剤
|
|
AU2003235913A1
(en)
|
2002-05-09 |
2003-11-11 |
Taisho Pharmaceutical Co., Ltd. |
Cyanopyrrolidine derivatives
|
|
JP2003327532A
(ja)
|
2002-05-10 |
2003-11-19 |
Takeda Chem Ind Ltd |
ペプチダーゼ阻害剤
|
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
CN100402026C
(zh)
|
2002-06-03 |
2008-07-16 |
诺瓦提斯公司 |
取代的氰基吡咯烷和含有它们的组合制剂用于治疗高脂血症和相关疾病的用途
|
|
JP2005533771A
(ja)
|
2002-06-04 |
2005-11-10 |
ファイザー・プロダクツ・インク |
ジペプチジルペプチダーゼｉｖ阻害剤としてのフッ素化環式アミド
|
|
US6710040B1
(en)
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
|
WO2003101449A2
(en)
|
2002-06-04 |
2003-12-11 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
|
MXPA04012226A
(es)
|
2002-06-06 |
2005-04-08 |
Eisai Co Ltd |
Nuevos derivados de imidazola.
|
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
|
JP2004026678A
(ja)
|
2002-06-24 |
2004-01-29 |
Microbial Chem Res Found |
２型糖尿病治療剤
|
|
US20050084490A1
(en)
|
2002-07-09 |
2005-04-21 |
Point Therapeutics, Inc. |
Boroproline compound combination therapy
|
|
WO2004007446A1
(ja)
|
2002-07-10 |
2004-01-22 |
Yamanouchi Pharmaceutical Co., Ltd. |
新規なアゼチジン誘導体又はその塩
|
|
US7208498B2
(en)
|
2002-07-15 |
2007-04-24 |
Merck & Co., Inc. |
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
|
AU2003253369A1
(en)
|
2002-07-29 |
2004-02-16 |
Tanabe Seiyaku Co., Ltd. |
Three-dimensional structure of dipeptidyl peptidase iv
|
|
AU2003254852A1
(en)
|
2002-08-08 |
2004-02-25 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds as peptidase inhibitors
|
|
JP4542757B2
(ja)
|
2002-08-08 |
2010-09-15 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
DE10238243A1
(de)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1532149B9
(de)
|
2002-08-21 |
2011-04-20 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
8-[3-amino-piperidin-1-yl] -xanthine, deren herstellung und deren verwendung als arzneimittel
|
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2004019352A1
(ja)
|
2002-08-26 |
2004-03-04 |
Matsushita Electric Industrial Co., Ltd. |
マルチフェーズ用磁性素子とその製造方法
|
|
ZA200501418B
(en)
|
2002-08-29 |
2006-10-25 |
Taisho Pharmaceutical Co Ltd |
Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
|
|
US8895541B2
(en)
|
2002-09-04 |
2014-11-25 |
James A. Carnazza |
Methods for inhibiting the development of huntington's disease
|
|
WO2004024184A1
(ja)
|
2002-09-11 |
2004-03-25 |
Takeda Pharmaceutical Company Limited |
徐放性製剤
|
|
US20040121964A1
(en)
|
2002-09-19 |
2004-06-24 |
Madar David J. |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7238724B2
(en)
|
2002-09-19 |
2007-07-03 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
ATE370141T1
(de)
|
2002-10-07 |
2007-09-15 |
Merck & Co Inc |
Antidiabetische heterocyclische beta- aminoverbindungen als inhibitoren von dipeptidylpeptidase
|
|
AU2003269850A1
(en)
|
2002-10-08 |
2004-05-04 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
|
KR20050067418A
(ko)
|
2002-10-18 |
2005-07-01 |
머크 앤드 캄파니 인코포레이티드 |
당뇨병을 치료 또는 예방하기 위한 베타-아미노헤테로사이클릭 디펩티딜 펩티다제 억제제
|
|
DE60332856D1
(de)
|
2002-10-23 |
2010-07-15 |
Bristol Myers Squibb Co |
Auf glycinnitril basierende hemmer der dipeptidylpeptidase iv
|
|
WO2004041795A1
(en)
|
2002-10-30 |
2004-05-21 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
|
AU2003280680A1
(en)
|
2002-11-01 |
2004-06-18 |
Sumitomo Pharmaceuticals Co., Ltd. |
Xanthine compound
|
|
EP1562925B1
(en)
|
2002-11-07 |
2007-01-03 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
EP1565437A1
(en)
|
2002-11-18 |
2005-08-24 |
Pfizer Products Inc. |
Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides
|
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
DE10256264A1
(de)
|
2002-12-03 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
|
AU2003297564A1
(en)
|
2002-12-04 |
2004-06-23 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
US7420079B2
(en)
|
2002-12-09 |
2008-09-02 |
Bristol-Myers Squibb Company |
Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
|
|
ES2311117T3
(es)
|
2002-12-10 |
2009-02-01 |
Novartis Ag |
Combinacion de un inhibidor de dpp-iv y un compuesto ppar-alfa.
|
|
WO2004058266A1
(en)
|
2002-12-20 |
2004-07-15 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
WO2004064778A2
(en)
|
2003-01-17 |
2004-08-05 |
Merck & Co. Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
JP2004244412A
(ja)
|
2003-01-20 |
2004-09-02 |
Kotobuki Seiyaku Kk |
４位に置換基を有する２−シアノピロリジン誘導体及びその製造方法並びにそれを含有する薬剤
|
|
JP4345313B2
(ja)
|
2003-01-24 |
2009-10-14 |
株式会社日立製作所 |
ポリシーに基づいたストレージシステムの運用管理方法
|
|
WO2004069162A2
(en)
|
2003-01-31 |
2004-08-19 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
PT1595866T
(pt)
|
2003-01-31 |
2016-09-14 |
Sanwa Kagaku Kenkyusho Co |
Cianopirrolidinas úteis para o tratamento entre outras de síndrome metabólica
|
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
|
WO2004076434A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
AU2003207881A1
(en)
|
2003-02-28 |
2004-09-17 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
AR043515A1
(es)
|
2003-03-19 |
2005-08-03 |
Merck & Co Inc |
Procedimiento para preparar derivados quirales beta aminoacidos mediante hidrogenacion asimetrica
|
|
WO2004085661A2
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc |
Process to chiral beta-amino acid derivatives
|
|
US7550590B2
(en)
|
2003-03-25 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2004087650A2
(en)
|
2003-03-27 |
2004-10-14 |
Merck & Co. Inc. |
Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
|
|
WO2004092128A1
(en)
|
2003-04-10 |
2004-10-28 |
Smithkline Beecham Corporation |
Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile
|
|
WO2004096806A1
(ja)
|
2003-04-30 |
2004-11-11 |
Sumitomo Pharmaceuticals Co. Ltd. |
縮合イミダゾール誘導体
|
|
US20040229848A1
(en)
|
2003-05-05 |
2004-11-18 |
Hans-Ulrich Demuth |
Glutaminyl based DP IV-inhibitors
|
|
US20040224995A1
(en)
|
2003-05-09 |
2004-11-11 |
University Of North Texas Health Science Center At Fort Worth |
Neuroprotective effects of PPARy agonists against cellular oxidative insults
|
|
WO2004103993A1
(en)
|
2003-05-14 |
2004-12-02 |
Syrrx, Inc. |
Dipeptidyl peptidase inhibitors
|
|
WO2004103276A2
(en)
|
2003-05-14 |
2004-12-02 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
EP1627870A1
(en)
|
2003-05-15 |
2006-02-22 |
Taisho Pharmaceutical Co., Ltd |
Cyanofluoropyrrolidine derivative
|
|
EP1631680A2
(en)
|
2003-05-21 |
2006-03-08 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
|
|
WO2004104215A2
(en)
|
2003-05-21 |
2004-12-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7)
|
|
AU2003902828A0
(en)
|
2003-06-05 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
EP1635832A2
(en)
|
2003-06-06 |
2006-03-22 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes
|
|
WO2004110436A1
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
CN1809544A
(zh)
|
2003-06-17 |
2006-07-26 |
麦克公司 |
作为二肽基肽酶抑制剂用于治疗或预防糖尿病的环己基甘氨酸衍生物
|
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
RU2339636C2
(ru)
|
2003-06-20 |
2008-11-27 |
Ф.Хоффманн-Ля Рош Аг |
Гексагидропиридоизохинолины в качестве ингибиторов дипептидилпептидазы iv (dpp-iv)
|
|
ES2355105T3
(es)
|
2003-06-20 |
2011-03-22 |
F. Hoffmann-La Roche Ag |
Pirido(2,1-a)isoquinolina como inhibidores de la dpp-iv.
|
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
JP2005023038A
(ja)
|
2003-07-04 |
2005-01-27 |
Taisho Pharmaceut Co Ltd |
慢性腎疾患治療薬
|
|
AU2004259741A1
(en)
|
2003-07-21 |
2005-02-03 |
Smithkline Beecham Corporation |
(2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
|
|
PE20050249A1
(es)
|
2003-07-25 |
2005-06-01 |
Aventis Pharma Gmbh |
Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos
|
|
US7094800B2
(en)
|
2003-07-25 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Cyanopyrrolidides, process for their preparation and their use as medicaments
|
|
US7008957B2
(en)
|
2003-07-25 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
|
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US20050065183A1
(en)
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
|
AU2004261186A1
(en)
|
2003-07-31 |
2005-02-10 |
Merck & Co., Inc. |
Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
DE10337074A1
(de)
|
2003-08-12 |
2005-03-17 |
Keyneurotek Ag |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention von chronischen neurodegenerativen Erkrankungen
|
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
KR20060041309A
(ko)
|
2003-08-13 |
2006-05-11 |
다케다 야쿠힌 고교 가부시키가이샤 |
４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도
|
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
|
EP1659123A1
(en)
|
2003-08-29 |
2006-05-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
Bicyclic pyrazole derivative
|
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
|
CA2536251C
(en)
|
2003-09-02 |
2009-08-04 |
Merck & Co., Inc. |
Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
WO2005030751A2
(en)
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
US7790734B2
(en)
|
2003-09-08 |
2010-09-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
AR046330A1
(es)
|
2003-09-09 |
2005-12-07 |
Japan Tobacco Inc |
Inhibidor de dipeptidilpeptidasa iv
|
|
GB0321100D0
(en)
|
2003-09-09 |
2003-10-08 |
Celltech R&D Ltd |
Biological products
|
|
WO2005030127A2
(en)
|
2003-09-23 |
2005-04-07 |
Merck & Co., Inc. |
Novel crystalline form of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor
|
|
US20070072810A1
(en)
|
2003-10-03 |
2007-03-29 |
Takeda Pharmaceutical Company, Limited |
Agent for treating diabetes
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
DE10348022A1
(de)
|
2003-10-15 |
2005-05-25 |
Imtm Gmbh |
Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
DE10348044A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200519105A
(en)
|
2003-10-20 |
2005-06-16 |
Lg Life Science Ltd |
Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
|
|
US20070123470A1
(en)
|
2003-10-24 |
2007-05-31 |
Wladimir Hogenhuis |
Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue
|
|
TW200528440A
(en)
|
2003-10-31 |
2005-09-01 |
Fujisawa Pharmaceutical Co |
2-cyanopyrrolidinecarboxamide compound
|
|
MXPA06004639A
(es)
|
2003-10-31 |
2006-06-27 |
Takeda Pharmaceutical |
Preparacion solida que comprende sensibilizador de insulina, secretagogo de insulina y ester de acidos grasos de polioxietileno sorbitano.
|
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
|
JP2007510651A
(ja)
|
2003-11-04 |
2007-04-26 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼ−ｉｖ阻害剤としての縮合フェニルアラニン誘導体
|
|
US7767828B2
(en)
|
2003-11-12 |
2010-08-03 |
Phenomix Corporation |
Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US7317109B2
(en)
|
2003-11-12 |
2008-01-08 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
NZ547752A
(en)
|
2003-11-12 |
2009-12-24 |
Phenomix Corp |
Heterocyclic boronic acid compounds for inhibiting dipeptidyl peptidase-IV
|
|
KR20120008093A
(ko)
|
2003-11-17 |
2012-01-25 |
노파르티스 아게 |
디펩티딜 펩티다제 ⅳ 억제제의 용도
|
|
US20070149451A1
(en)
|
2003-11-17 |
2007-06-28 |
Holmes David G |
Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
|
|
US20070105890A1
(en)
|
2003-11-26 |
2007-05-10 |
Dainippon Sumitomo Pharma Co., Ltd |
Novel condensed imidazole derivative
|
|
DE10355304A1
(de)
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7504423B2
(en)
|
2003-12-11 |
2009-03-17 |
Mitsubishi Tanabe Pharma Corporation |
α-amino acid derivatives and use thereof as medicines
|
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
|
US7217711B2
(en)
|
2003-12-17 |
2007-05-15 |
Boehringer Ingelheim International Gmbh |
Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2005072530A1
(en)
|
2004-01-16 |
2005-08-11 |
Merck & Co., Inc. |
Novel crystalline salts of a dipeptidyl peptidase-iv inhibitor
|
|
EP1559419A1
(en)
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
|
|
KR20050076924A
(ko)
|
2004-01-26 |
2005-07-29 |
삼성전자주식회사 |
양방향 통신이 가능한 ｉ2ｃ 통신시스템 및 그 방법
|
|
US7230002B2
(en)
|
2004-02-03 |
2007-06-12 |
Glenmark Pharmaceuticals Ltd. |
Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
|
|
WO2005075426A1
(en)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
|
AU2005215136A1
(en)
|
2004-02-20 |
2005-09-01 |
Novartis Ag |
DPP-IV inhibitors for treating neurodegeneration and cognitive disorders
|
|
US20050203027A1
(en)
|
2004-02-23 |
2005-09-15 |
Trustees Of Tufts College |
Inhibitors of dipeptidylpeptidase IV
|
|
CN101090885A
(zh)
|
2004-02-23 |
2007-12-19 |
塔夫茨大学信托人 |
作为构象限定的肽模拟物抑制剂的内酰胺类化合物
|
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
|
US20050250820A1
(en)
|
2004-03-08 |
2005-11-10 |
Amgen Inc. |
Therapeutic modulation of PPARgamma activity
|
|
US20050215603A1
(en)
|
2004-03-08 |
2005-09-29 |
Irini Akritopoulou-Zanze |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7348346B2
(en)
|
2004-03-08 |
2008-03-25 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US20070093492A1
(en)
|
2004-03-09 |
2007-04-26 |
Weir-Torn Jiaang |
Pyrrolidine derivatives
|
|
EP1729774A4
(en)
|
2004-03-09 |
2009-05-06 |
Nat Health Research Institutes |
PYRROLIDINE CONNECTIONS
|
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
|
CN102127057A
(zh)
|
2004-03-15 |
2011-07-20 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
|
ATE557013T1
(de)
|
2004-03-16 |
2012-05-15 |
Boehringer Ingelheim Int |
Glucopyranosyl-substituierte benzol-derivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
|
|
US20050215882A1
(en)
|
2004-03-23 |
2005-09-29 |
The Regents Of The University Of Michigan |
Noninvasive method to determine fat content of tissues using MRI
|
|
TW200538122A
(en)
|
2004-03-31 |
2005-12-01 |
Bristol Myers Squibb Co |
Process for preparing a dipeptidyl peptidase Ⅳ inhibitor and intermediates employed therein
|
|
US7179809B2
(en)
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
|
CA2562391A1
(en)
|
2004-04-14 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Solid pharmaceutical preparation
|
|
US7741082B2
(en)
|
2004-04-14 |
2010-06-22 |
Bristol-Myers Squibb Company |
Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
|
|
TW200536827A
(en)
|
2004-05-04 |
2005-11-16 |
Bristol Myers Squibb Co |
Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
|
|
AU2005247895A1
(en)
|
2004-05-18 |
2005-12-08 |
Merck & Co., Inc. |
Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
|
JP2008501714A
(ja)
|
2004-06-04 |
2008-01-24 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼインヒビター
|
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
|
EP1782828B1
(en)
|
2004-07-21 |
2016-06-29 |
Kissei Pharmaceutical Co., Ltd. |
Progression inhibitor for disease attributed to abnormal accumulation of liver fat
|
|
RU2369865C2
(ru)
|
2004-07-23 |
2009-10-10 |
Электрик Пауэ Рисеч Инститьют, Инк. |
Гибкий электромагнитный акустический преобразователь
|
|
US7054436B2
(en)
|
2004-08-02 |
2006-05-30 |
Sony Ericsson Mobile Communication, Ab |
Communication terminals with a dual use speaker for sensing background noise and generating sound, and related methods and computer program products
|
|
US20060046978A1
(en)
|
2004-08-31 |
2006-03-02 |
Morphochem Ag |
Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)
|
|
DE102004043944A1
(de)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
|
WO2006034435A2
(en)
|
2004-09-21 |
2006-03-30 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
|
AR051446A1
(es)
|
2004-09-23 |
2007-01-17 |
Bristol Myers Squibb Co |
Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
|
|
BRPI0516340A
(pt)
|
2004-10-12 |
2008-09-16 |
Glenmark Pharmaceuticals Sa |
composto, composição farmacêutica, método para tratar uma condição que é regulada ou normalizada via inibição de dpp-iv, método para tratar um distúrbio metabólico, método para tratar diabete tipo ii, método para diminuir glicose no sangue, método para tratamento e profilaxia de uma doença, método para tratar toleráncia não prejudicada a glicose insulino-resistente, método para a manufatura de uma composição farmacêutica e processo para a preparação de compostos
|
|
JP2008515978A
(ja)
|
2004-10-13 |
2008-05-15 |
ユニバーシティ オブ コネチカット |
カンナビネルジック脂質リガンド
|
|
US20060252670A1
(en)
|
2004-10-14 |
2006-11-09 |
Intercept Pharmaceuticals Inc. |
Method of reducing drug-induced adverse side effects in a patient
|
|
EP1656934A1
(en)
*
|
2004-11-12 |
2006-05-17 |
Cognis IP Management GmbH |
Use of physiologically active fatty acids for treating lipodystrophy
|
|
EP1851216A2
(en)
|
2004-11-30 |
2007-11-07 |
F.Hoffmann-La Roche Ag |
Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
|
|
CA2587639A1
(en)
|
2004-12-16 |
2006-06-22 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
US7411093B2
(en)
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
|
CN101090888A
(zh)
|
2004-12-20 |
2007-12-19 |
霍夫曼-拉罗奇有限公司 |
4－氨基哌啶衍生物
|
|
WO2006068978A2
(en)
|
2004-12-21 |
2006-06-29 |
Takeda Pharmaceutial Company Limited |
Dipeptidyl peptidase inhibitors
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
EP1888571A2
(en)
|
2005-03-22 |
2008-02-20 |
F. Hoffmann-Roche AG |
New salt and polymorphs of a dpp-iv inhibitor
|
|
AU2006239929B2
(en)
|
2005-04-22 |
2011-11-03 |
Alantos Pharmaceuticals Holding, Inc. |
Dipeptidyl peptidase-IV inhibitors
|
|
US7723309B2
(en)
|
2005-05-03 |
2010-05-25 |
Boehringer Ingelheim International Gmbh |
Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-((R)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7644148B2
(en)
|
2005-05-16 |
2010-01-05 |
Hewlett-Packard Development Company, L.P. |
Historical data based workload allocation
|
|
US7521557B2
(en)
|
2005-05-20 |
2009-04-21 |
Bristol-Myers Squibb Company |
Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
US20060264433A1
(en)
|
2005-05-23 |
2006-11-23 |
Backes Bradley J |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
|
US20060270722A1
(en)
|
2005-05-31 |
2006-11-30 |
Thornberry Nancy A |
Combination of a dipeptidyl peptidase-IV inhibitor and a dual PPAR agonist for the treatment of diabetes and obesity
|
|
EP1905450A1
(en)
|
2005-07-12 |
2008-04-02 |
Daiichi Sankyo Company, Limited |
Pharmaceutical composition containing ppar gamma agonist
|
|
AU2006278039B2
(en)
|
2005-08-11 |
2010-10-21 |
F. Hoffmann-La Roche Ag |
Pharmaceutical composition comprising a DPP-lV inhibitor
|
|
US7425633B2
(en)
|
2005-08-26 |
2008-09-16 |
National Health Research Institutes |
Pyrrolidine compounds
|
|
JP2009508815A
(ja)
|
2005-08-30 |
2009-03-05 |
アボット・ラボラトリーズ |
ジペプチジルペプチダーゼ−ｉｖ（ｄｐｐ−ｉｖ）の阻害薬としての医薬組成物
|
|
CA2620566A1
(en)
|
2005-08-30 |
2007-03-08 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
|
|
TW200745075A
(en)
|
2005-09-08 |
2007-12-16 |
Boehringer Ingelheim Int |
Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-(4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments
|
|
AR056195A1
(es)
|
2005-09-15 |
2007-09-26 |
Boehringer Ingelheim Int |
Procedimientos para preparar derivados de (etinil-bencil)-benceno sustituidos de glucopiranosilo y compuestos intermedios de los mismos
|
|
AT502717A1
(de)
|
2005-11-09 |
2007-05-15 |
Omnica Gmbh |
Pharmazeutische verwendung einer verbindung
|
|
WO2007054577A1
(en)
|
2005-11-14 |
2007-05-18 |
Probiodrug Ag |
Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
|
|
JP2009520742A
(ja)
|
2005-12-21 |
2009-05-28 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｄｐｐ−ｉｖ阻害剤の新規な塩および多形
|
|
ZA200805147B
(en)
|
2005-12-22 |
2010-05-26 |
Takeda Pharmaceutical |
Solid preparation
|
|
WO2007093610A1
(en)
|
2006-02-15 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
|
US20070239536A1
(en)
|
2006-04-05 |
2007-10-11 |
General Electric Company |
System and method for scheduling audience deficiency units and makegoods
|
|
PE20080697A1
(es)
|
2006-05-03 |
2008-08-05 |
Boehringer Ingelheim Int |
Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
|
|
PL2032134T3
(pl)
*
|
2006-05-09 |
2015-11-30 |
Genzyme Corp |
Sposoby leczenia stłuszczeniowej choroby wątroby obejmujące hamowanie syntezy glikosfingolipidów
|
|
EP2046292B1
(en)
|
2006-07-21 |
2010-03-03 |
Novartis AG |
Formulations for benzimidazolyl pyridyl ethers
|
|
US8283326B2
(en)
|
2006-10-27 |
2012-10-09 |
Boehringer Ingelheim International Gmbh |
Crystalline form of 4-(beta-D-glucopyranos-1-yl)-1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
|
|
AR063569A1
(es)
|
2006-11-06 |
2009-02-04 |
Boehringer Ingelheim Int |
Derivados de benzil- benzonitrilo sustituidos con glucopiranosilo medicamentos que contienen a compuestos de este tipo su uso u procedimiento para su fabricacion
|
|
AU2007316613B2
(en)
|
2006-11-09 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
Combination therapy with SGLT-2 inhibitors and their pharmaceutical compositions
|
|
WO2008067378A2
(en)
|
2006-11-28 |
2008-06-05 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted phenyltetrazoles
|
|
US20070172525A1
(en)
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
|
CA2721133C
(en)
|
2007-04-13 |
2018-11-06 |
Somaxon Pharmaceuticals, Inc. |
Low-dose doxepin formulations and methods of making and using the same
|
|
WO2009007673A2
(en)
|
2007-07-11 |
2009-01-15 |
Cardoz Ab |
Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
|
|
WO2009015179A1
(en)
|
2007-07-23 |
2009-01-29 |
Syndax Pharmaceuticals, Inc. |
Novel compounds and methods of using them
|
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术（上海）有限公司 |
白介素-22在治疗脂肪肝中的应用
|
|
WO2009097997A1
(de)
|
2008-02-07 |
2009-08-13 |
Sanofi-Aventis |
Substituierte imidazolidin-2,4-dione, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
|
|
WO2009097996A1
(de)
|
2008-02-07 |
2009-08-13 |
Sanofi-Aventis |
Verwendung von substituierten phenylimidazolidinen zur herstellung von arzneimitteln zur behandlung des metabolischen syndroms
|
|
US20130245024A1
(en)
*
|
2008-03-06 |
2013-09-19 |
Dennis Lanfear |
Combination of PPARy Agonist and a Dipeptidyl Peptidase-Inhibitor for the Treatment of Diabetes and Obesity
|
|
JPWO2009151116A1
(ja)
*
|
2008-06-13 |
2011-11-17 |
持田製薬株式会社 |
非アルコール性脂肪肝炎の予防／改善・治療薬
|
|
WO2010040055A2
(en)
|
2008-10-03 |
2010-04-08 |
Intekrin Therapeutics, Inc. |
Oral pharmaceutical formulations for antidiabetic compounds
|
|
JP2010265216A
(ja)
|
2009-05-14 |
2010-11-25 |
Takeda Chem Ind Ltd |
複素環化合物
|
|
EP2448412B1
(en)
|
2009-07-01 |
2019-05-01 |
JDS Therapeutics, LLC |
Chromium complexes as enhancers of brain glucose transporters
|
|
WO2011017488A2
(en)
*
|
2009-08-05 |
2011-02-10 |
Intekrin Therapeutics, Inc. |
Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity
|
|
WO2012040082A2
(en)
|
2010-09-21 |
2012-03-29 |
Intekrin Therapeutics, Inc. |
Antidiabetic solid pharmaceutical compositions
|
|
US8477001B2
(en)
|
2010-09-21 |
2013-07-02 |
Remy Technologies Llc |
Starter solenoid with rectangular coil winding
|
|
JP5719443B2
(ja)
|
2010-09-26 |
2015-05-20 |
ダ・ユー・エンタープライジズ、エルエルシー |
組換え巨大分子製造方法
|
|
WO2012071459A1
(en)
|
2010-11-22 |
2012-05-31 |
The Regents Of The University Of California |
New indication for use of niacin (nicotinic acid) for treatment, prevention and reversal of fatty liver disease
|
|
TWI435605B
(zh)
|
2010-11-29 |
2014-04-21 |
Realtek Semiconductor Corp |
透過高解析度多媒體介面來進行網路連線之網路裝置及網路連線方法
|
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
|
US8865641B2
(en)
|
2011-06-16 |
2014-10-21 |
The Feinstein Institute For Medical Research |
Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
|
|
WO2013052813A1
(en)
|
2011-10-06 |
2013-04-11 |
Vanderbilt University |
Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome
|
|
WO2013071077A1
(en)
|
2011-11-09 |
2013-05-16 |
Cornell University |
The use of pan-ppar agonists for prevention and treatment of huntington's disease and tauopathies
|
|
JP5525511B2
(ja)
*
|
2011-12-27 |
2014-06-18 |
農業生産法人株式会社 熱帯資源植物研究所 |
非アルコール性脂肪性肝疾患および／または非アルコール性脂肪肝炎の治療薬
|
|
KR101186500B1
(ko)
|
2012-01-31 |
2012-09-27 |
연세대학교 산학협력단 |
신규한 피페린 유도체 및 그의 용도
|
|
WO2013134241A1
(en)
|
2012-03-05 |
2013-09-12 |
The University Of Montana |
Novel aspartylamide inhibitors of excitatory amino acid transporters
|
|
US20140107154A1
(en)
|
2012-10-12 |
2014-04-17 |
Teva Pharmaceutical Industries, Ltd. |
Laquinimod for reducing thalamic damage in multiple sclerosis
|
|
KR102056756B1
(ko)
|
2013-01-30 |
2019-12-17 |
인테크린 테라퓨틱스, 아이엔씨. |
다발성 경화증의 치료를 위한 PPARγ 작용제
|
|
US10441560B2
(en)
|
2013-03-15 |
2019-10-15 |
Mochida Pharmaceutical Co., Ltd. |
Compositions and methods for treating non-alcoholic steatohepatitis
|
|
ES2662108T3
(es)
|
2013-03-15 |
2018-04-05 |
Somalogic, Inc. |
Biomarcadores de la enfermedad de hígado graso no alcohólico (EHGNA) y de la esteatohepatitis no alcohólica (EHNA) y usos de los mismos
|
|
TWI696462B
(zh)
*
|
2013-07-10 |
2020-06-21 |
日商興和股份有限公司 |
非酒精性脂肪性肝疾病治療劑
|
|
TW201609098A
(zh)
|
2013-12-20 |
2016-03-16 |
泰瓦藥品工業有限公司 |
拉喹莫德（ｌａｑｕｉｎｉｍｏｄ）於延緩亨丁頓舞蹈症進展的用途
|
|
EP3110507B1
(en)
|
2014-02-27 |
2020-11-18 |
NuSirt Sciences, Inc. |
Compositions and methods for the reduction or prevention of hepatic steatosis
|
|
ES2785317T3
(es)
|
2014-10-10 |
2020-10-06 |
Liminal Biosciences Ltd |
Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y el tratamiento de la osteoporosis
|
|
CN104299589B
(zh)
|
2014-10-29 |
2016-05-25 |
京东方科技集团股份有限公司 |
移位寄存器单元电路、移位寄存器、驱动方法及显示装置
|
|
KR20160061492A
(ko)
|
2014-11-21 |
2016-06-01 |
삼성디스플레이 주식회사 |
휴대용 먼지 센서 및 이를 이용한 휴대전화
|
|
EA201791982A1
(ru)
|
2015-03-09 |
2020-02-17 |
Интекрин Терапьютикс, Инк. |
Способы лечения неалкогольной жировой болезни печени и/или липодистрофии
|
|
US10894054B2
(en)
|
2015-04-07 |
2021-01-19 |
Intercept Pharmaceuticals, Inc. |
FXR agonist compositions for combination therapy
|
|
WO2017139588A1
(en)
|
2016-02-12 |
2017-08-17 |
Indiana University Research & Technology Corporation |
Lysosomal acid lipase and ppar gamma ligands as an immune therapies for cancer treatment
|
|
ES2866883T3
(es)
|
2016-06-08 |
2021-10-20 |
Support Venture Gmbh |
Combinaciones farmacéuticas para el tratamiento del cáncer
|
|
CA3034258A1
(en)
|
2016-08-18 |
2018-02-22 |
Intekrin Therapeutics, Inc. |
Ppar.gamma. agonist for treatment of blood cancers
|
|
AU2017313842A1
(en)
|
2016-08-18 |
2019-03-07 |
Intekrin Therapeutics, Inc. |
PPARgamma AGONIST FOR TREATMENT OF BONE DISORDERS
|
|
SG10202102198RA
(en)
|
2016-09-13 |
2021-04-29 |
Intekrin Therapeutics Inc |
Treatment of multiple sclerosis with chs-131
|
|
US11350844B2
(en)
|
2016-11-23 |
2022-06-07 |
Mayo Foundation For Medical Education And Research |
System and method for generating nonalcoholic fatty liver disease activity score (NAS) using magnetic resonance elastography
|
|
WO2018131626A1
(ja)
|
2017-01-11 |
2018-07-19 |
興和株式会社 |
非アルコール性脂肪性肝疾患の予防及び治療薬
|
|
SG11201906644YA
(en)
|
2017-01-18 |
2019-08-27 |
Coherus Biosciences Inc |
Pparϒ agonist for the treatment of huntington's disease
|
|
AU2018249822A1
(en)
|
2017-04-03 |
2019-10-31 |
Coherus Biosciences Inc. |
PPArgamma agonist for treatment of progressive supranuclear palsy
|
|
CN110536682B
(zh)
|
2017-04-18 |
2023-01-06 |
基恩菲特公司 |
依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合
|
|
EA201992364A1
(ru)
|
2018-04-02 |
2020-03-23 |
Кохерус Байосайенсис Инк. |
АГОНИСТ PPARγ ДЛЯ ЛЕЧЕНИЯ ПРОГРЕССИРУЮЩЕГО НАДЪЯДЕРНОГО ПАРАЛИЧА
|
|
EP3906022A1
(en)
|
2018-12-31 |
2021-11-10 |
Coherus Biosciences, Inc. |
Compositions and methods to treat non-alcoholic fatty liver diseases (nafld)
|
|
US20220193102A1
(en)
|
2019-04-02 |
2022-06-23 |
Coherus Biosciences, Inc. |
Compositions and methods to treat non-alcoholic fatty liver diseases (nafld)
|
|
WO2020205025A1
(en)
|
2019-04-04 |
2020-10-08 |
Coherus Biosciences, Inc. |
Compositions and methods to treat non-alcoholic fatty liver diseases (nafld)
|
|
WO2021076616A1
(en)
|
2019-10-15 |
2021-04-22 |
Coherus Biosciences, Inc. |
Compositions and methods to treat non-alcoholic fatty liver diseases (nafld)
|